首页> 美国卫生研究院文献>BMC Bioinformatics >Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition
【2h】

Prediction of drug-disease associations based on ensemble meta paths and singular value decomposition

机译:基于整体元路径和奇异值分解的药物-疾病关联预测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIn the field of drug repositioning, it is assumed that similar drugs may treat similar diseases, therefore many existing computational methods need to compute the similarities of drugs and diseases. However, the calculation of similarity depends on the adopted measure and the available features, which may lead that the similarity scores vary dramatically from one to another, and it will not work when facing the incomplete data. Besides, supervised learning based methods usually need both positive and negative samples to train the prediction models, whereas in drug-disease pairs data there are only some verified interactions (positive samples) and a lot of unlabeled pairs. To train the models, many methods simply treat the unlabeled samples as negative ones, which may introduce artificial noises. Herein, we propose a method to predict drug-disease associations without the need of similarity information, and select more likely negative samples.
机译:背景技术在药物重新定位领域中,假设相似的药物可以治疗相似的疾病,因此许多现有的计算方法需要计算相似的药物和疾病。但是,相似度的计算取决于所采用的度量和可用功能,这可能导致相似度得分之间存在很大差异,并且在面对不完整的数据时将不起作用。此外,基于监督学习的方法通常都需要正样本和负样本来训练预测模型,而在药物-疾病对数据中,只有一些经过验证的相互作用(阳性样本)和许多未标记的对。为了训练模型,许多方法只是将未标记的样本视为负样本,这可能会引入人为噪声。在本文中,我们提出了一种无需相似信息即可预测药物-疾病关联的方法,并选择更可能的阴性样品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号